A US study has concluded that weight gain is greater by around 2 to 4 kg in HIV-positive people taking bictegravir or dolutegravir as part of their first antiretroviral therapy (ART), compared to their counterparts using other drug regimens. A similar effect was reported in those using the protease inhibitor darunavir. The study led by… Read More »
Dolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women. UNC’s Lameck Chinula presented findings at the 2020 Conference on Retroviruses and Opportunistic Infections. UNC’s Jeffrey Stringer is a study investigator. The antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and most effective HIV treatment regimen currently available… Read More »
Cutaneous melanoma, also called malignant melanoma, is the type of skin cancer that is most likely to spread to other parts of the body. Though melanoma accounts for only about 1% of skin cancers, it is responsible for more than 90% of skin cancer-related deaths. But thanks to developments in skin cancer treatment (mostly in… Read More »
For critically ill children, fresh blood transfusions may be no better than blood that has been stored for several weeks. Transfusions in seriously ill children are usually given to improve oxygen delivery and prevent organ failure, and some studies have suggested that newer blood is better. Now a blinded, randomized trial has found it is… Read More »